Warner Chilcott Company, Inc. and Paratek Pharmaceuticals, Inc. announced today that the two companies have entered into an exclusive license agreement for the development and commercialization of novel, narrow-spectrum tetracyclines for the treatment of acne and rosacea.
From: biz.yahoo.com
Warner Chilcott and Paratek Pharmaceuticals Sign Collaboration Agreement for Novel, Narrow-Spectrum Agents for Acne and ...
Posted by Ruslan Abuzant at 6:14 AM
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment